Predictors of angiographic restenosis after drug eluting stents in the coronary arteries: contemporary practice in real world patients

被引:103
作者
Rathore, Sudhir [1 ]
Terashima, Mitsuyasu [1 ]
Katoh, Osamu [1 ]
Matsuo, Hitoshi [1 ]
Tanaka, Noboyushi [1 ]
Kinoshita, Yoshihisa [1 ]
Kimura, Masashi [1 ]
Tuschikane, Etsuo [1 ]
Nasu, Kenya [1 ]
Ehara, Mariko [1 ]
Asakura, Keiko [1 ]
Asakura, Yasushi [1 ]
Suzuki, Takahiko [1 ]
机构
[1] Toyohashi Heart Ctr, Dept Cardiol, Toyohashi, Aichi 4418530, Japan
关键词
Drug-eluting stent; restenosis; IVUS; predictors; DIABETES-MELLITUS; IMPLANTATION; OUTCOMES; IMPACT; DISEASE;
D O I
10.4244/V5I3A55
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: Drug eluting stents (DES) have been used routinely in a wide variety of clinical situations. The impact of DES on reducing restenosis has not been uniform across complex subsets and limited data is available examining predictors of restenosis in unselected population. Methods and results: We investigated predictors of angiographic restenosis in an unselected population. The study population consisted of 4,143 lesions and angiographic follow-up was available for 3,020(73%) lesions in 1,885 patients. The intravascular ultrasound (IVUS) was used in 95% of the patients during the procedure. Angiographic restenosis was seen in 339 (11.2%) lesions and target lesion revascularisation was performed in 290 (9.6%) lesions. The patient population included large numbers of renal failure patients on haemodialysis, ISR, and Type C lesions with routine use of intravascular ultrasound. We identified diabetes mellitus, renal failure, Type C lesions, calcified lesion, tortuous lesion, ISR, long lesion, small baseline diameter and final vessel diameter as predictors of restenosis. On multivariate analysis diabetes (OR 1.45, 95% Cl 1.07-1.97, p= 0.01), renal failure on haemodialysis (OR 2.02, 95% Cl 1.37-3.27, p=0.001), ISR (OR 3.56, 95% Cl 2.16-5.89, P<0.001), lesion length (OR 1.02, CI 1.01-1.03.P<0.001), reference vessel diameter (OR 0.50, 95% CI 0.31-0.80, p=0.005) and post-intervention IVUS lumen area (p<0.001) were independent predictors of angiographic restenosis. Female gender (OR 0.61, 95% Cl 0.410.91, p=0.015) was found to have a negative correlation for ISR. We did not find any significant difference in restenosis between the usage of sirolimus and paclitaxel eluting stents. Conclusions: DES usage was associated with overall low in-stent restenosis and we have identified several clinical, angiographic, and IVUS predictors of angiographic restenosis in unselected patients with complex anatomy.
引用
收藏
页码:349 / 354
页数:6
相关论文
共 28 条
[1]   Sirolimus-eluting stents vs bare metal stents for coronary intervention in Japanese patients with renal failure on hemodialysis [J].
Aoyama, Toru ;
Ishii, Hideki ;
Toriyama, Takanobu ;
Takahashi, Hiroshi ;
Kasuga, Hirotake ;
Murakami, Ryuichiro ;
Amano, Tetsuya ;
Uetani, Tadayuki ;
Yasuda, Yoshinari ;
Yuzawa, Yukio ;
Maruyama, Shoichi ;
Matsuo, Seiichi ;
Matsubara, Tatsuaki ;
Murohara, Toyoaki .
CIRCULATION JOURNAL, 2008, 72 (01) :56-60
[2]   Incidence and predictors of restenosis after sirolimus-eluting stent implantation in high-risk patients [J].
Berenguer, A ;
Mainar, V ;
Bordes, P ;
Valencia, J ;
Gómez, S ;
Lozano, T .
AMERICAN HEART JOURNAL, 2005, 150 (03) :536-542
[3]   RESTENOSIS AFTER ARTERIAL INJURY CAUSED BY CORONARY STENTING IN PATIENTS WITH DIABETES-MELLITUS [J].
CARROZZA, JP ;
KUNTZ, RE ;
FISHMAN, RF ;
BAIM, DS .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (05) :344-349
[4]   Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions [J].
Colombo, A ;
Drzewiecki, J ;
Banning, A ;
Grube, E ;
Hauptmann, K ;
Silber, S ;
Dudek, D ;
Fort, S ;
Schiele, F ;
Zmudka, K ;
Guagliumi, G ;
Russell, ME .
CIRCULATION, 2003, 108 (07) :788-794
[5]   Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement [J].
Elezi, S ;
Kastrati, A ;
Pache, J ;
Wehinger, A ;
Hadamitzky, M ;
Dirschinger, J ;
Neumann, FJ ;
Schömig, A .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (07) :1866-1873
[6]  
Fitzgerald PJ, 2000, CIRCULATION, V102, P523
[7]   Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis [J].
Fujii, K ;
Mintz, GS ;
Kobayashi, Y ;
Carlier, SG ;
Takebayashi, H ;
Yasuda, T ;
Moussa, I ;
Dangas, G ;
Mehran, R ;
Lansky, AJ ;
Reyes, A ;
Kreps, E ;
Collins, M ;
Colombo, A ;
Stone, GW ;
Teirstein, PS ;
Leon, MB ;
Moses, JW .
CIRCULATION, 2004, 109 (09) :1085-1088
[8]  
Halkin Amir, 2006, J Invasive Cardiol, V18, P577
[9]  
Halkin Amir, 2004, J Interv Cardiol, V17, P271, DOI 10.1111/j.1540-8183.2004.04040.x
[10]  
Hassani Salah-Eddine, 2006, J Invasive Cardiol, V18, P273